Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomesNeil M Bressler, Miroslav Veith, Jan Hamouz, Jan Ernest, Dominik Zalewski, Jan Studnička, Attila Vajas, András Papp, Gabor Vogt, James Luu, Veronika Matuskova, Young Hee Yoon, Tamás Pregun, Taehyung Kim, Donghoon Shin
See the full list of authors16 October 2021
Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapyMengyuan Fang, Karntida Chanwimol, Jyotsna Maram, Ghazala A Datoo O'Keefe, Charles C Wykoff, David Sarraf, A’sha Brown, Shaun Ian Retief Lampen, Brenda Zhou, Alexander M Rusakevich, SriniVas Sadda
24 September 2021
Contrast sensitivity and quality of life following intravitreal ranibizumab injection for central retinal vein occlusionTomoya Murakami, Fumiki Okamoto, Yoshimi Sugiura, Shohei Morikawa, Yoshifumi Okamoto, Takahiro Hiraoka, Tetsuro Oshika
27 August 2021
Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX studySamantha Fraser-Bell, Hyong Kwon Kang, Paul Mitchell, Jennifer J Arnold, Jodi Tainton, Susan Simonyi
25 August 2021
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registryAdrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, Socorro Alforja, Pierre-Henry Gabrielle, Javier Zarranz-Ventura, Martin Guillemin, Samantha Fraser-Bell, Ricardo P Casaroli Marano, Jennifer Arnold, Ian L McAllister, Louise O'Toole, Mark C Gillies, Daniel Barthelmes, Hemal Mehta
12 March 2021
Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trialZhenquan Wu, Jinfeng Zhao, Waiching Lam, Mingmin Yang, Lu Chen, Xuelin Huang, Meirong Wei, Hui Yang, Fan Lv, Fuyan Zhang, Jian Zeng, Guo-Ming Zhang
26 February 2021
Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyesThomas Ciulla, John S Pollack, David F Williams
14 October 2020
Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosaStacey A Strong, Tunde Peto, Catey Bunce, Wen Xing, Michalis Georgiou, Simona Degli Esposti, Angelos Kalitzeos, Andrew Webster, Michel Michaelides
25 August 2020
Prediction of visual outcomes by an artificial neural network following intravitreal injection and laser therapy for retinopathy of prematurityChing-Yen Huang, Ren-Jieh Kuo, Cheng-Han Li, Daniel S Ting, Eugene Yu-Chuan Kang, Chi-Chun Lai, Hsiao-Jung Tseng, Lan-Yan Yang, Wei-Chi Wu
25 August 2020
Brolucizumab: the road aheadAshish Sharma, Nilesh Kumar, Francesco Bandello, Baruch D Kuppermann, Anat Loewenstein, Carl D Regillo
22 August 2020
